Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Jurnal Ekonomi
Annisa Lukman A. Gaffar
Mahasiswa Magister Manajemen STIEM Bongaya
Economics, Econometrics & Finance

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Adakah Perbedaan Kinerja Keuangan Perusahaan Farmasi Sebelum dan Selama Covid-19? Annisa Lukman A. Gaffar; Rabihatun; La Ode Sumail
Jurnal Ekonomi Vol. 27 No. 2 (2022): July 2022
Publisher : Fakultas Ekonom dan Bisnis, Universitas Tarumanagara

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24912/je.v27i2.1076

Abstract

The purpose of this research is to investigate whether there are significant differences in financial performance before Covid-19 and during Covid-19 in pharmaceutical companies listed on the IDX. The sample of this study was 9 companies and all of the population were sampled so that this study used the saturated sample technique. The analytical method used is a comparative test with a Paired T-test approach. The results of the study that ROE had a significant difference between before and during Covid-19 also had an impact on stock prices. Furthermore, the DPR has a significant difference between before and during Covid-19 so that it has an impact on stock prices. And lastly, PER has a significant difference between before and during Covid-19 which also has an impact on stock prices.
Co-Authors Rabihatun Sumail, La Ode